Malik Muhammad, Hussain Syed, Drlica Karl
Public Health Research Institute, 225 Warren Street, Newark, NJ 07103, USA.
Antimicrob Agents Chemother. 2007 Jan;51(1):28-34. doi: 10.1128/AAC.00739-06. Epub 2006 Oct 16.
Quinolone activity against Escherichia coli was examined during aerobic growth, aerobic treatment with chloramphenicol, and anaerobic growth. Nalidixic acid, norfloxacin, ciprofloxacin, and PD161144 were lethal for cultures growing aerobically, and the bacteriostatic activity of each quinolone was unaffected by anaerobic growth. However, lethal activity was distinct for each quinolone with cells treated aerobically with chloramphenicol or grown anaerobically. Nalidixic acid failed to kill cells under both conditions; norfloxacin killed cells when they were grown anaerobically but not when they were treated with chloramphenicol; ciprofloxacin killed cells under both conditions but required higher concentrations than those required with cells grown aerobically; and PD161144, a C-8-methoxy fluoroquinolone, was equally lethal under all conditions. Following pretreatment with nalidixic acid, a shift to anaerobic conditions or the addition of chloramphenicol rapidly blocked further cell death. Formation of quinolone-gyrase-DNA complexes, observed as a sodium dodecyl sulfate (SDS)-dependent drop in cell lysate viscosity, occurred during aerobic and anaerobic growth and in the presence and in the absence of chloramphenicol. However, lethal chromosome fragmentation, detected as a drop in viscosity in the absence of SDS, occurred with nalidixic acid treatment only under aerobic conditions in the absence of chloramphenicol. With PD161144, chromosome fragmentation was detected when the cells were grown aerobically and anaerobically and in the presence and in the absence of chloramphenicol. Thus, all quinolones tested appear to form reversible bacteriostatic complexes containing broken DNA during aerobic growth, during anaerobic growth, and when protein synthesis is blocked; however, the ability to fragment chromosomes and to rapidly kill cells under these conditions depends on quinolone structure.
在需氧生长、氯霉素需氧处理及厌氧生长过程中,对喹诺酮类药物针对大肠杆菌的活性进行了检测。萘啶酸、诺氟沙星、环丙沙星和PD161144对需氧生长的培养物具有致死性,且每种喹诺酮类药物的抑菌活性不受厌氧生长的影响。然而,对于在需氧条件下用氯霉素处理或厌氧生长的细胞,每种喹诺酮类药物的致死活性有所不同。萘啶酸在这两种条件下均无法杀死细胞;诺氟沙星在细胞厌氧生长时可杀死细胞,但在细胞用氯霉素处理时则不能;环丙沙星在这两种条件下均可杀死细胞,但所需浓度高于需氧生长的细胞;而C-8-甲氧基氟喹诺酮类药物PD161144在所有条件下均具有同等致死性。用萘啶酸预处理后,转为厌氧条件或添加氯霉素会迅速阻止进一步的细胞死亡。在需氧和厌氧生长过程中以及存在和不存在氯霉素的情况下,均会形成喹诺酮-gyrase-DNA复合物,这表现为细胞裂解液粘度的十二烷基硫酸钠(SDS)依赖性下降。然而,仅在需氧条件下且不存在氯霉素时,用萘啶酸处理才会导致致死性染色体断裂(表现为无SDS时粘度下降)。对于PD161144,在细胞需氧和厌氧生长时以及存在和不存在氯霉素的情况下均检测到染色体断裂。因此,所有测试的喹诺酮类药物在需氧生长、厌氧生长以及蛋白质合成受阻时似乎都会形成含有断裂DNA的可逆抑菌复合物;然而,在这些条件下使染色体断裂并迅速杀死细胞的能力取决于喹诺酮类药物的结构。